Relocating the Testicles Under the Skin of the Thigh to Shield Them From Radiation

Twelve children, with a median age of 12.8 years, and a question that has haunted pediatric oncology services for decades: how to irradiate a pelvic tumor without destroying the patient’s future fertility? In the face of this puzzle, a team of surgeons devised a solution as discreet as it is ingenious: physically moving an entire organ out of the path of the rays. A technical feat that, although still largely unknown to the general public, tangibly changes the lives of many young patients.

When Radiation Threatens Fertility: The Dilemma of Pelvic Radiotherapies

Radiotherapy remains one of the pillars of treatment for many pediatric cancers, notably sarcomas, lymphomas, and certain leukemias with testicular involvement. The problem arises when the tumor lies in the pelvic region or in close proximity to the scrotum: the beams designed to destroy cancer cells inevitably pass through nearby healthy tissues. The testicles are among the most radiosensitive organs in the human body: a relatively modest dose can permanently impair their hormonal function and their ability to produce sperm.

For a long time, doctors had little choice but to accept this collateral damage, with the cancer being the top priority. But as survival rates among young patients continued to improve, the question of quality of life after cure moved to the center of care protocols. Preserving fertility is no longer just a comfort; it has become a therapeutic goal in its own right, on par with eradicating the tumor itself.

The Testicular Transposition: Removing the Organ from the Line of Fire

This is where a technique as little known as it is effective comes into play: the testicular transposition. The principle is almost childlike in its logic, yet its execution requires surgical precision. It simply involves temporarily moving the testicle away from the radiation area by relocating it under the skin of the thigh, at the anteromedial region—that is, in front and slightly inward on the thigh.

Concretely, the surgeon makes a small incision and creates a subcutaneous pocket just beneath the skin. A tunnel is then fashioned to the perineum, allowing the spermatic cord—the delicate structure that carries blood vessels and the deferent ducts—to descend without torsion or excessive tension. Any error at this stage could cut off the organ’s blood supply, so the maneuver must be performed with extreme care. The testicle is guided through this tunnel to its new position, where it is secured with permanent sutures. The procedure can involve one side or both, depending on the tumor’s configuration and the treatment plan.

This approach even has a female counterpart that is much better documented: ovarian transposition, which moves the ovaries out of the radiation field before pelvic radiotherapy, following the exact same principle. In boys, however, the technique remains far less frequently reported in the medical literature, with only rare clinical cases published to date.

A Quiet Surgery, Life-Changing Outcomes

What stands out in the available data is the low complication rate associated with this intervention. Surgeons describe minimal morbidity, i.e., few side effects or risks tied to the operation itself, while achieving a dramatic reduction in the dose of radiation reaching the healthy testicle. In other words, the organ is effectively protected without adding significant risk to the patient.

Endocrine function, meaning the production of hormones such as testosterone, appears broadly preserved after this type of transposition. However, data on long-term fertility remain incomplete, due to insufficiently long follow-up on large patient cohorts. This is indeed one of the current limits of the technique: its still relatively limited adoption restricts the amount of clinical feedback available to precisely evaluate all long-term benefits on fertility.

One reassuring detail to note: this relocation is not permanent. After the radiotherapy is completed, the testicle can be replaced in the scrotum during a second surgical procedure called an orchidopexy. The initial move is thus only an anatomical detour, a temporary detour designed to protect the organ while the rays do their job against the tumor.

What This Technique Reveals About the Future of Fertility Preservation

Beyond the specific case of relocating the testicle to the thigh, other surgical variants continue to be explored to further refine protection of reproductive organs. Some teams have developed an alternative method for children treated with brachytherapy for bladder or prostate rhabdomyosarcomas. In this version, the spermatic cord is mobilized up to the external inguinal ring, after which the testicle is gently turned over and wrapped in a silicone material before being sutured beneath the abdominal skin rather than under the thigh.

These successive innovations illustrate a trend at the heart of modern pediatric oncology: treating cancer is no longer enough; there is now an emphasis on anticipating life after cure. Fertility preservation fits within this logic, alongside procedures such as freezing gametes or reproductive tissues before particularly heavy treatments. Testicular transposition represents a surgical version of this concept, less familiar to the public but equally indicative of the desire to think beyond mere survival.

That said, the technique remains relatively confidential, reserved for specialized centers capable of coordinating surgeons and radiotherapists around a meticulous protocol. Its broader dissemination will likely depend on the publication of more long-term follow-up data, particularly regarding the fertility of patients who have grown into adults.

This tale of a temporarily exiled testicle in the thigh captures the spirit of contemporary medicine: to find sometimes unexpected solutions to preserve what matters, without ever sacrificing the effectiveness of the primary treatment. One question remains, though: will these surgical techniques eventually become generalized enough to become a standard of care, rather than a qualified option available only at a few pioneering centers?